Form 4: Humana Director Boosts Stake with RSU Grants and Deferrals

Humana Director David T. Feinberg increased his beneficial ownership through the acquisition of restricted stock units and deferred stock unit conversions.

Summary

• David T. Feinberg, a Director at Humana Inc. (HUM), reported changes in his beneficial ownership of company securities.
• Feinberg acquired 766 restricted stock units (RSUs) of Humana Common Stock on January 2, 2026, as a contingent right to receive shares under the company's 2019 Amended & Restated Plan.
• He also acquired 70 restricted stock units on December 31, 2025, by electing to convert a director's cash fee into stock units at a price of $258.8675 per unit.
• An additional 29 restricted stock units were acquired on December 31, 2025, through the reinvestment of dividend payments on vested and deferred stock units, also at a price of $258.8675 per unit.
• Following these transactions, Feinberg directly beneficially owns 1,207 shares of Humana Common Stock.
• He also directly beneficially owns 1,593 restricted stock units from annual director's fees, 708 restricted stock units from cash fee conversions, and 46 restricted stock units from dividend reinvestments, all deferred and payable 1-for-1 in common stock.

Sentiment

Score: 7

Explanation: The sentiment is slightly positive as a director is increasing their beneficial ownership in the company through compensation and deferral mechanisms, which aligns their interests with shareholders. These are routine transactions, not open market purchases, so the positive impact is moderate.

Positives

• The director's beneficial ownership of Humana stock and stock units has increased, which generally aligns management interests with those of shareholders.
• The acquisitions are primarily through compensation and dividend reinvestment, indicating a commitment to holding company equity.

Risks

• The value of the acquired restricted stock units is tied to the future performance of Humana Inc. common stock, exposing the director to market fluctuations.
• Deferred compensation arrangements mean the director's payout is subject to the company's long-term stability and stock price at the time of vesting/payment.

Future Outlook

This filing does not contain forward-looking statements or guidance regarding the company's future performance or outlook.

Industry Context

Insider transactions, such as those reported in a Form 4, are common in publicly traded companies as part of executive and director compensation plans. The acquisition of stock units by a director is generally viewed as a positive signal of confidence in the company's future prospects, aligning the director's financial interests with those of shareholders.

Related Party Transactions

• The transactions involve David T. Feinberg, a Director of Humana Inc., acquiring restricted stock units from the company as part of his compensation and through dividend reinvestment, which are considered related party transactions.

Stakeholder Impact

• Shareholders: Increased director ownership can signal confidence in the company's future, potentially fostering investor trust and aligning director incentives with shareholder value creation.
• Employees: No direct impact on employees is indicated by this filing.

Key Dates

Recommendation

This Form 4 filing details routine insider transactions related to director compensation and deferral. While an increase in director ownership is generally positive, these are not open market purchases and do not provide new fundamental information about the company's operational or financial performance that would warrant a change in investment recommendation based solely on this filing. Investors should consider broader company fundamentals and market conditions.

Keywords

Humana, HUM, Form 4, Insider Transaction, Director, Restricted Stock Units, RSU, Beneficial Ownership, Stock Compensation, Dividend Reinvestment